Genetic Analysis, Genetics and Licensing - Clinical Research Informer

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Genetic Analysis

Genetics

Licensing

What Do Patients Have to Say about Gene Therapy Trials? An Upcoming FDA Public Meeting to Hear from Patients and Caregivers

FDA Law Blog

MARCH 13, 2023

The treatment consists of inserting healthy genes into an affected individual’s affected cells and tissues to try and stop or treat the disease.

Gene Therapy

Gene Therapy Gene Trials Clinical Trials

Solving the Global Clinical Trial Gap: The Case for Partnering with Multisite Lab Services

XTalks

DECEMBER 1, 2020

As the research and medical community learns more about population variances in disease outcomes, whether as a result of regional genetic profiles, socioeconomic factors, or environmental inputs, it’s become necessary to ensure that clinical research trials include broad swaths of global participants.

Clinical Trials

Clinical Trials Clinical Trials Trials Clinical Research

Fighting viruses is as easy as breathing

The Pharma Data

APRIL 8, 2022

Based on these studies, one of those drugs was licensed to Cantex Pharmaceuticals for the treatment of COVID-19 and other inflammatory lung diseases. They also identified several drugs that reduced the production of inflammatory cytokines in infected Alveolus Chips, which could be useful in treating excessive inflammation in the lung.

Immune Response

Immune Response In-Vivo Genetic Analysis Research

Webinars

Bridging Innovation & Patient Care: The Growing Role of AI

MORE WEBINARS

What Do Patients Have to Say about Gene Therapy Trials? An Upcoming FDA Public Meeting to Hear from Patients and Caregivers

Solving the Global Clinical Trial Gap: The Case for Partnering with Multisite Lab Services

Fighting viruses is as easy as breathing

Webinars

Stay Connected